Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Alopecia areata significantly lowers quality of life, especially in personal and social areas, and more so if the patient is also depressed.

Researchers created a fast, accurate computer program to measure hair loss in alopecia areata patients.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Tofacitinib may help treat severe hair loss, but more research is needed.

Baricitinib is effective and safe for treating severe alopecia areata.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Trichoscopy is useful for diagnosing and monitoring alopecia areata treatment.

This therapy effectively treats resistant alopecia areata with minimal side effects.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Both dermatologists and patients in Japan agree that treatment success for alopecia areata is having 20% or less scalp hair loss.

Intralesional corticosteroids are the best for limited alopecia areata, oral steroids are less effective, and PRP is safe and promising, especially for children and severe cases.

People with alopecia areata have higher levels of osteopontin, which might be important in the disease's development, but this doesn't relate to how severe the disease is.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Higher Claudin 3 levels in the blood are linked to more severe alopecia areata.

Dermoscopy helps diagnose and manage alopecia areata by showing specific hair changes.

1% anthralin ointment is effective and safe for treating severe alopecia areata in children.

The conclusion is that understanding and addressing the psychological effects of alopecia areata is important for effective treatment.

Cryotherapy and steroid injections are similarly effective and safe for treating alopecia areata.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

The PRP-like cosmetic product with postbiotics effectively treats hair loss in Alopecia areata.

People with alopecia areata often have lower vitamin D levels, which may be linked to the condition's severity.

Wharton's jelly-derived stem cells were safely used to treat four alopecia patients, resulting in hair regrowth in all of them.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Patient-reported outcomes better reflect the quality of life impact of alopecia areata than traditional severity scores.

People with alopecia areata often have low vitamin D levels, which may worsen their hair loss.